Sphere Fluidics appoints Richard Hammond as Chief Technical Officer

Sphere Fluidics, a Cambridge, UK company developing single cell analysis systems underpinned by its patented picodroplet technology, has appointed Richard Hammond as Chief Technical Officer.

In his role as Chief Technical Officer, Richard will be responsible for driving innovation and growing Sphere Fluidics’ product range, including productizing several patented prototypes currently in development. Alongside the expansion of the senior team in May 2021, his appointment is part of the company’s plans to expand its portfolio of single cell analysis and monoclonality assurance systems to facilitate accelerated biotherapeutic discovery and development.

Richard Hammond, MA MEng, joins Sphere Fluidics with over 20 years’ experience in managing the development of cutting-edge commercial products for healthcare and life sciences.

Hammond has held numerous senior positions, including leading product and technology development at Alere, Cambridge Consultants and DNA Electronics. With extensive technical expertise, he has worked in cutting-edge research areas, such as automated cell transfection, CAR-T cell therapy manufacture and digital data storage in DNA. Richard holds MA and MEng degrees in engineering from King’s College, University of Cambridge.